News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Hidehito Horinouchi: HARMONi-A – Chemo +/- Ivonescimab in EGFRm NSCLC after EGFR-TKIs resistance
Jun 1, 2024, 10:17

Hidehito Horinouchi: HARMONi-A – Chemo +/- Ivonescimab in EGFRm NSCLC after EGFR-TKIs resistance

Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital, recently shared a post on X:

“ASCO24 Abstracts

No. 8508 HARMONi-A: Chemo +/- Ivonescimab (AK112/SMT112, anti-PD-1/VEGF bispecific ab) in EGFRm NSCLC after EGFR-TKIs resistance
Presenter: Dr. Li Zhang

  • PFS HR 0.46 (95%CI: 0.34, 0.62),
  • Phase III,
  • Primary PFS,
  • NCT05184712.”

Source: Hidehito Horinouchi/X

ASCO24 cancer EGFR mutation in NSCLC HARMONi-A trial Hidehito Horinouchi ivonescimab Li Zhang National Cancer Center Hospital NSCLC OncoDaily Oncology
Special Coverage
Insight
Nov 13, 2024, 07:12
Luigi Lorini was awarded the 2024 Martin "Mac" Cheever Excellence in Clinical Trial Design Travel Award for Immunoprevention
Blog
Nov 12, 2024, 23:10
Hesham ElGhazaly: Empowering Women’s Health Through Solidarity
Blog
Nov 12, 2024, 23:07
Helen’s Journey with Breast Cancer - The Max Foundation
Blog
Nov 12, 2024, 22:58
Webinar on Lung Cancer Highlights from ESMO 2024 - SPCC
Blog
Nov 12, 2024, 22:56
Sanjay Juneja: The Challenge of Innovation in Cancer Treatment
Blog
Nov 12, 2024, 22:52
Session on cervical cancer screening programs and managing cervical pre-cancer in women living with HIV at IPVC 2024 - IARC
Blog
Nov 12, 2024, 22:50
Penilla Gunther: First time speaking at the POLITICO Europe Healthcare Summit
Blog
Nov 12, 2024, 22:46
Addressing AMR for Better Cancer Care During London Global Cancer Week - UICC
Blog
Nov 12, 2024, 22:43
Applications Open for 2025 CancerX Accelerator - CancerX Moonshot
Blog
Nov 12, 2024, 22:40
Wafik S. El-Deiry: Welcoming Dr. Dinara Ryspayeva to Brown University for Therapeutic Advances in Oncology
Celebrities
Nov 12, 2024, 19:50
Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More
Blog
Nov 12, 2024, 19:38
Alfredo Colina on comparing real-time multimodal analysis of CAR-T cells to more traditional phenotypic and functional assays